Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells

Soaring Biomedical IPOs Raise Questions About Money Left on the Table

Berkeley Lights Will Receive IPO of the Year Award at SynBioBeta 2020

Optofluidics Technology Accelerates Discovery of COVID-19 Treatments

Q&A: Distributed Biological Processing Can Prevent Pandemics

Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion

Health Care CEO Does 180 Zoom Calls In Three Days to Help Take Company Public

A Singular View of COVID-19

Samsung Biologics Launches S-CHOice Cell Line Expression Technology

Light-Based Chips Speed up Cell-Line Development for GSK

Berkeley Lights flies high with $178M IPO

Berkeley Lights, Inc. Rings the Opening Bell in Celebration of its IPO

As We Wait for a Vaccine, Scientists Work to Scale Up the Best COVID-19 Antibodies to Give New Patients

Get to IND Faster: Accelerated and High-Performance Cell-Line Development

Optofluidics Aids Cell Line Development for Antibody-Based Therapies

Antibody Therapies to Cure Coronavirus Now Under Human Trial Phase

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

The Race Is On to Find the Holy Grail of Covid-19 Antibodies

1
2
3